Over 200 separate indications or uses for medical cannabis have been identified Nation wide but under the Compassionate Use Program.
- ALS (Amyotrophic lateral sclerosis)
- Alzheimer’s Disease
- Dementias
- Autism & Other Spectrum Disorders
- Cancer
- Peripheral Neuropathy
- MS (Multiple Sclerosis)
- Parkinson’s Disease
- Epilepsy & Other Seizure Disorders
- CTE (Chronic Traumatic Encephalopathy)
- Spasticity
- PTSD (Posttraumatic Stress Disorder)
- ADENYLOSUCCINATE SYNTHASE DEFICIENCY
- ALEXANDER DISEASE AMYLOIDOSIS
- ARGYROPHILIC GRAIN DISEASE
- ASPARYLGLUCOSAMINURIA
- ATAXIA NEUROPATHY SPECTRUM
- BIDIRECTIONAL ENZYME DEFICIENCY
- BIOPTERIN DEFECTS
- CANAVAN DISEASE
- CENTRAL CORE
- CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY
- CHARCOT MARIE TOOTH AND RELATED HEREDITARY
- NEUROPATHIES
- CHILDHOOD MYOCEREBROHEPATOPATHY SPECTRUM
- CONGENITAL DISORDERS OF GLYCOSYLATION
- CORTICOBASAL DEGENERATION
- CREATINE DISORDERS
- CREATINE TRANSPORTER DEFECT, ALSO KNOWN AS SLC 6A8
- DEMENTIA WITH LEWY BODIES
- DEOXYGUANISINE KINASE DEFICIENCY
- DIHYDROPIRIMIDINASE DEFICIENCY
- DIHYDROPTERIDINE REDUCTASE
- DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY
- DUCHENNE MUSCULAR DYSTROPHY
- FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
- FAMILIAL OR SPORADIC FATAL INSOMNIA
- FAMILIAL SPASTIC PARAPLEGIA
- FARBER DISEASE
- FATTY ACID OXIDATION
- FREIDREICH’S ATAXIA
- FRONTOTEMPORAL DEMENTIA AND PARKINSONISM
- LINKED TO CHROMOSOME 17 CAUSED BY MUTATIONS IN MAPT GENE
- FRONTOTEMPORAL LOBAR DEGENERATION
- GALACTOSEMIA
- GALACTOSIALIDOSIS GAUCHER TYPE 2 AND TYPE 3
- GLOBULAR GLIAL TAUOPATHY
- GLUTARIC ACIDEMIA TYPE 1
- GLYCINE ENCEPHALOPATHY ALSO KNOWN AS GM1
- GANGLIOSIDOSIS AND SANDHOFF DISEASE
- GUANIDINOACETATE METHYTRANSFERASE DEFICIENCY
- GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE DEFICIENCY
- HUNTINGTON’S DISEASE
- KEARN SAYERS SYNDROME
- KRABBE
- KURU
- LEUKODYSTROPHY
- LEWY BODY DISORDERS
- LYSOSOMAL STORAGE DISEASES
- MANNOSIDOSIS
- MANOSIDOSIS ALPHA AND BETA
- MAPLE SYRUP URINE DISEASE
- METACHROMATIC LEUKODYSTROPHY
- METAL METABOLISM
- METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY
- SEVERE VARIANT
- MITOCHONDRIAL CONDITIONS
- MITOCHONDRIAL DEPLETION SYNDROMES TYPES 1 THROUGH 14
- MITOCHONDRIAL ENCEPHALOPATHY LACTIC ACIDOSIS STROKE
- MITOCHONDRIAL ENCEPHALOPATHY RAGGED RED FIBER
- MITOCHONDRIAL NEUROGASTROINTESTINAL
- ENCEPHALOPATHY MONOAMINE OXIDASE DEFICIENCY
- MOTOR NEURON DISEASE
- MUCOLIPIDOSES
- MUCOLIPIDOSES TYPE II, ALSO KNOWN AS INCLUSION CELL DISEASE
- MUCOLIPIDOSES TYPE III, ALSO KNOWN AS MUCOPOLYSACCARIDOSIS
- MUCOPOLYSACCHARIDOSIS TYPE I ALSO KNOWN AS HURLER SYNDROME OR SCHEIE SYNDROME
- MUCOPOLYSACCHARIDOSIS TYPE II ALSO KNOWN AS HUNTER SYNDROME
- MUCOPOLYSACCHARIDOSIS TYPE III ALSO KNOWN AS SANFILIPPO A AND B
- MUCOPOLYSACCHARIDOSIS TYPE IV ALSO KNOWN AS MAROTEAUX-LAMY
- MUCOPOLYSACCHARIDOSIS TYPE VII, ALSO KNOWN AS SLY
MULTIPLE SULFATASE DEFICIENCY - MULTIPLE SYSTEM ATROPHY
- MUSCULAR DYSTROPHIES
- MYOCLONIC EPILEPSY MYOPATHY SENSORY ATAXIA
- NEIMANN PICK TYPE A AND B
- NEIMANN PICK TYPE C
- NEONATAL ADRENOLEUKODYSTROPHY
- NEURODEGENERATION WITH BRAIN IRON ACCUMULATION
- NEUROFIBRILLARY TANGLE DEMENTIA, ALSO KNOWN BATTEN DISEASE
- NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA
- NEUROTRANSMITTER DEFECTS
- LIGOSACCHARIDOSES
- PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION
- PARKINSON’S DISEASE
- PERIPHERAL NEUROPATHY TYPES 1 THROUGH 4
- PEROXISOMAL BIOSYNTHESIS DEFECTS
- PEROXISOMAL DISORDERS
- PICK DISEASE
- POLYMERASE G RELATED DISORDERS
- POLYOL DISORDERS
- PRIMARY LATERAL SCLEROSIS
- PRION DISEASES
- PROGRESSIVE CHOREAS
- PROGRESSIVE DYSTONIAS DYT GENES 1 THROUGH 20
- PROGRESSIVE MUSCULAR ATROPHY
- PROGRESSIVE SUPRANUCLEAR PALSY
- PURINE AND PYRIMIDINE DEFECTS
- PYRUVATE CARBOXYLASE DEFICIENCY
- PYRUVATE DEHYDROGENASE DEFICIENCY
- REFSUM DISEASE
- RESPIRATORY CHAIN DISORDERS COMPLEX 1 THROUGH 4 DEFECTS: COQ BIOSYNTHESIS DEFECTS
- SALIDOSIS
- SCHINDLER
- SEGAWA DISEASE ALSO KNOWN AS DOPAMINE RESPONSIVE DYSTONIA
- SEPIAPTERIN REDUCTASE
- SIALIDOSIS
- SPHINGOLIPIDOSES
- SPINAL MUSCULAR ATROPHY
- SPINOCEREBELLAR ATAXIA
- SUBACUTE NECROTIZING ENCEPHALOPATHY, ALSO KNOWN AS LEIGH SYNDROME
- ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA SYNUCLEINOPATHIES
- TAUOPATHIES
- THYMIDINE KINASE
- PROTEINOPATHIES
- TRIFUNCTIONAL PROTEIN DEFICIENCY
- NEUROTRANSMITTER DEFECTS VASCULAR DEMENTIA
- NEUROTRANSMITTER DEFECTS WILSON DISEASE
- NEUROTRANSMITTER DEFECTS ZELLWEGER SYNDROME